Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
66711 studies found for:    pharmacology
Show Display Options
Rank Status Study
1 Completed Robotic Pharmacological Anesthesia System for Elective Cardiac Surgery
Condition: Cardiac Surgery
Intervention: Device: Test of pharmacologic anesthesia robot (labVIEW® software)
2 Completed Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: electrical cardioversion;   Drug: propafenone
3 Completed Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
Condition: Healthy
Interventions: Drug: MDA;   Drug: Placebo
4 Completed A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects
Condition: Clinical Pharmacology
Interventions: Drug: TAK-233;   Drug: Placebo
5 Completed Abuse Liability and Human Pharmacology of Mephedrone
Condition: Amphetamine-Related Disorders
Interventions: Drug: Mephedrone;   Drug: 3,4-methylenedioxymethamphetamine;   Drug: Placebo
6 Completed Tenofovir Pharmacology in Older HIV Infected Individuals
Conditions: HIV;   Aging
Intervention: Drug: iohexol
7 Completed Pharmacological Aids for Interactive Smoking Cessation
Condition: Smoking Cessation
Interventions: Behavioral: Smokefree Partners: 21 Days to Freedom;   Other: Wait-List Control
8 Completed Pilot Study of Pharmacology of Paracetamol Administered Per-oral Mucosa
Condition: Healthy
Interventions: Drug: Kinetics of plasma concentrations of paracetamol;   Drug: Placebo
9 Withdrawn Pharmacology Study of Aerosolized Liposomal
Conditions: Lung Diseases;   Cancer
Intervention: Drug: L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin
10 Completed
Has Results
Study of Pharmacology of 17-OHPC in Pregnancy
Condition: Pregnancy
Interventions: Drug: 17-OHPC;   Procedure: Blood Draws
11 Withdrawn Pharmacology of Exenatide in Pediatric Sepsis
Conditions: Septic Shock;   Inflammation;   Glucose Homeostasis;   Organ Dysfunction;   Health-related Quality of Life
Interventions: Drug: Exenatide;   Drug: Exenatide vehicle
12 Recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy
13 Completed A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers
Condition: Osteoarthritis
Interventions: Drug: ONO-4474 Part A1;   Drug: Placebo Part A1;   Drug: ONO-4474 Part A2;   Drug: Placebo Part A2;   Drug: ONO-4474 Part B;   Drug: Placebo Part B;   Drug: ONO-4474 Part C;   Drug: Placebo Part C;   Drug: ONO-4474 Part D;   Drug: Placebo Part D
14 Completed Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
Condition: Rheumatoid Arthritis
Intervention: Drug: MRA(Tocilizumab)
15 Completed Alefacept Mechanism of Action in Psoriasis
Condition: Psoriasis
Intervention: Drug: Mechanism of action of alefacept
16 Completed Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and the Lung Availability of CHF 5993 in Healthy Volunteers
Condition: COPD
Interventions: Drug: CHF 5993 100/6/12,5 pMDI;   Drug: CHF 5993 100/6/12,5 DPI Test 1;   Drug: CHF 5993 100/6/12,5 DPI Test 2;   Drug: CHF 5993 100/6/12,5 pMDI replicate;   Drug: CHF 5993 100/6/12,5 pMDI with Valved Holding Chamber
17 Completed A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin
Conditions: Hypercholesterolemia;   Hyperlipoproteinemia
Interventions: Drug: Pravastatin;   Drug: Lifibrol
18 Completed Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
Condition: Asthma
Interventions: Drug: Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1;   Drug: CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).;   Drug: BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF);   Drug: CHF 1535 100/6 pMDI (Foster®) (CTR)
19 Completed Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma
Conditions: Advanced Solid Tumors;   Lymphomas
Intervention: Drug: Camptothecin-20-O-Propionate Hydrate (CZ48)
20 Unknown  Behavioral Pharmacology Associated With Cigar Smoking
Condition: Cigar Smoking
Intervention: Other: Smoking topography

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.